Seniors’ Access to Critical Medications Act of 2025

Bill 119 HR 2484, also known as the Seniors' Access to Critical Medications Act of 2025, aims to address the issue of rising prescription drug costs for senior citizens in the United States. The bill focuses on improving access to essential medications for older Americans by implementing several key provisions.

One of the main components of the bill is the establishment of a Medicare Part D out-of-pocket cap, which would limit the amount that seniors have to pay for prescription drugs each year. This cap is designed to provide financial relief for older Americans who may be struggling to afford their medications on a fixed income.

Additionally, the Seniors' Access to Critical Medications Act includes measures to increase transparency in drug pricing, such as requiring pharmaceutical companies to disclose the costs associated with developing and manufacturing their products. This information would help policymakers and consumers better understand the factors driving prescription drug prices. The bill also seeks to promote the use of generic and biosimilar medications as a way to lower costs for seniors. By encouraging the use of more affordable alternatives to brand-name drugs, the legislation aims to reduce the financial burden on older Americans who rely on prescription medications to manage their health conditions. Overall, Bill 119 HR 2484 represents a bipartisan effort to address the challenges faced by seniors in accessing critical medications. By implementing measures to limit out-of-pocket costs, increase transparency in drug pricing, and promote the use of generic and biosimilar medications, the legislation aims to improve the affordability and accessibility of prescription drugs for older Americans.